LAUREN BROWNE: Open Payments
NPI 1932744620 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 65 payments from 16 companies in 2025. Trend: 2023 $2,153 · 2024 $638 · 2025 $1,557
Food & beverage: $1,557
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 20 | $490 |
| GENZYME CORPORATION | 7 | $200 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $122 |
| Incyte Corporation | 5 | $108 |
| Botanix SB Inc | 4 | $103 |
| Galderma Laboratories, L.P. | 4 | $89 |
| Janssen Biotech, Inc. | 4 | $86 |
| ABBVIE INC. | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Organon LLC | 2 | $57 |
Products named: ADBRY, DUPIXENT, OPZELURA, SOFDRA, TREMFYA, NEMLUVIO, Winlevi, ILUMYA.
Industry payments across NY — which companies pay providers there.
